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A B S T R A C T
 
 
 
Introduction:  The ‘Commission on the Future of Health Care in Canada’ recognized that people living in rural and remote areas 
of Canada are at a disadvantage in health status, access to care and health professionals, and it considers the fight against these 
problems as a national priority. Although some attention has been paid to the prevalence of chronic diseases, very few studies have 
studied specifically the management and health issues in populations with chronic diseases in relation to rurality. The objective of 
this study was to describe systematic gaps across rural and urban populations in incidence, mortality, morbidity, material and 
human resources utilization, and drug management for three important chronic diseases: atherosclerosis, osteoporosis and diabetes.  
Methods:  Three retrospective population-based cohort studies were used. Three study populations were selected: an 
atherosclerotic population including patients newly hospitalized for a myocardial infarction (MI), an osteoporotic population 
including the at risk population who have suffered from a fragility fracture (FF) and, finally, a diabetic population that includes 
only incident cases of diabetes patients. For each of the three chronic diseases, variables were selected and classified in six 
categories: incidence, mortality, morbidity, material resources utilization, physician consultation and drug treatment. The Statistical 
Area Classification (SAC) was used as the rurality definition and contains six categories including two urban areas − Census 
Metropolitan Areas (CMA), or metropolitan areas, and Census Agglomeration (CA), or small towns − and four rural areas: Strong, 
Moderate, Weak and No Metropolitan influenced zones (MIZ), depending on the proportion of the workforce that commutes to 
urban areas. Each disease-related variable was described using age- and sex-adjusted rates. For comparing rates between rurality 
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classes, the adjusted relative risks were calculated using the CMA as the reference group. The χ2 was used to test for the equality of 
risks. 
Results:  A common pattern was identified from this study: for all three studied diseases, the material resources utilization rates 
and the specialist (other than internist) consultation rates were almost always statistically lower in small towns and rural areas 
when compared with metropolitan areas. Mortality rates and drug utilization rates were very similar among regions, except for 
hormone replacement therapy in women where utilization rates were higher in small towns and rural areas compared with 
metropolitan areas. Among observations that were not common to all three chronic diseases, the first is that MI incidence was 
greater in small towns and in Weak MIZ compared with metropolitan areas, fragility fractures seem to be marginally more frequent 
in small towns but less frequent in rural areas compared with metropolitan areas, while an increased incidence rate of diabetes is 
observed in remote region and a smaller risk in moderate MIZ compared with metropolitan areas. For both atherosclerosis and 
diabetes, morbidity rates were always statistically higher in small towns and in rural areas. This was not the case for patients with 
osteoporotic fractures where similar morbidity rates across regions were observed, except in strong MI which show the lowest 
morbidity rate.  
Conclusions:  There was substantially lower utilization of specialized services in non-metropolitan areas for all three diseases 
(myocardial infarction, osteoporosis, and diabetes). However, this did not translate into consistent differences in mortality and 
morbidity outcomes. This suggests that the impact of differential care utilization is specific to each disease, with indications that 
some important services may be under-utilized in rural areas, while others may be over-utilized in urban areas without 
improvement in outcomes. 
 
Key words:  atherosclerosis, chronic disease, diabetes, fragility fracture, health outcomes, health care management, myocardial 
infarction, osteoporosis, rurality. 
 
 
Introduction 
 
An important goal [in population health] is to 
minimize the disparities across population subgroups 
so that certain groups are not at a systematic 
disadvantage with regard to their access to health 
services and achievement of optimal health1. 
 
Approximately 30% of the population of Canada live in rural 
and remote areas which occupy approximately 95% of the 
territory2. The Quebec’s provincial government is also 
particularly preoccupied with rurality because its so-called 
geographical rural area is one of the largest in the world and 
contains approximately 20% of the Quebec population. 
Urban and rural health disparities in health care and 
outcomes of chronic diseases continue to be widely observed 
in many countries and settings3-14. Various factors may 
account for these geographic disparities. For example, it has 
been shown that rural populations are socio-economically 
disadvantaged15-17 and it has been proven that socioeconomic 
status has an impact on health18,19. Accessibility to health 
care and services, which is a constant concern for rural 
populations, must also be considered when examining these 
health disparities20,21. Because the industrialized countries 
seek to guarantee their citizens equity in health and care, the 
health of those living in rural areas represents a major 
interest. The ‘Commission on the Future of Health Care in 
Canada’ recognized that people living in rural and remote 
areas of Canada are at a disadvantage in health status, access 
to care and health professionals, and it considers the fight 
against these problems to be a national priority22.  
 
A 2006 Canadian report23 examined patterns of selected 
socio-demographic and economic characteristics, health 
status and health behaviors, focusing on the differences 
between rural and urban Canadians. This document was the 
first report ever produced at the pan-Canadian level that 
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provides a broad picture of the health of rural populations. 
While some health measures did not show any pronounced 
rural–urban differences, and some adverse health measures 
were found to be higher in urban areas, rural areas generally 
showed a health disadvantage for many health-related 
measures examined in the study. This report shows that, 
generally, rural residents of Canada are more likely to be in 
poorer socio-economic conditions, to have lower educational 
attainment, to exhibit less healthy behaviors and to have 
higher overall mortality rates than urban residents. In 
Quebec, a study published by the Institut national de la santé 
publique in 200424 showed very similar results to the 
Canadian study regarding selected health indicators such as 
mortality and health-related behaviors. 
 
Although some have studied the disparities in the 
management and health issues in populations with specific 
chronic diseases5-16,25-30, few studies have focused on a 
common pattern in the management of chronic disease in 
relation to rurality. This article examines the management 
and health issues of some major chronic diseases and their 
relationships with rural and urban populations of Quebec, 
Canada, in the early 2000s. More specifically, the objective 
was to describe systematic gaps between rural and urban 
populations in incidence, mortality, morbidity, material and 
human resources utilization, and drug management of 
specific chronic diseases.  
 
Methods 
 
Definition of rurality 
 
In Canada there is no consensus on an operational definition 
to measure the concept of rurality. At the Canadian 
government level, Statistics Canada and the Rural Secretariat 
use six different definitions to distinguish rural from urban 
areas31. The majority of these definitions use census tract as 
the unit of analysis, and population size and density as 
criteria for categorization. Depending on the definition used, 
the size and composition of the Canadian rural population 
varies from 22% to 38%32. The Statistical Area 
Classification (SAC) provides one of many definitions of 
rurality proposed by Statistics Canada33. It is the only 
definition that includes a functional criterion, namely, the 
commuter ratio. This ratio represents the percentage of a 
municipality’s residents who travel to work daily to an urban 
area. According to the SAC definition there are two 
categories of urban areas depending on the size of the urban 
core population: Census Metropolitan Areas (CMA) or 
metropolitan areas, with a population of at least 100 000, and 
Census Agglomerations (CA) or small towns, with a 
population between 10 000 and 99 99934. Metropolitan 
Influenced Zones (MIZ) or rural areas are assigned on the 
basis of the share of the workforce that commutes to any 
CMA or CA (Strong MIZ: between 30% and 50%; Moderate 
MIZ: between 5% and 30%; Weak MIZ more than 0% and 
less than 5%; No MIZ: no commuters)35. Details about SAC 
and the criteria employed for its development can be found 
on the Statistics Canada website (www.statcan.gc.ca). In this 
study, SAC definition based on 2001 census was used as 
shown (Fig1). 
 
Design and data sources 
 
This study used specific retrospective population-based 
cohort studies for three different chronic diseases. Patient 
data were obtained from the Quebec’s provincial hospital 
discharge register (MED-ECHO)36 and Quebec’s provincial 
demographic database which contains dates and causes of 
death. Physician visits and drug registers were obtained from 
the Régie de l’assurance maladie du Québec (RAMQ)37. The 
prescription claims database provides data on dispensed 
drugs (drug identification, date of dispensing, day of supply, 
cost and prescriber’s specialty) claimed by individuals 
within the public drug insurance plan, which covers more 
than 95% of all people aged 65 years and older, people on 
welfare and people not covered by a private drug insurance 
plan. Using a unique encrypted identifier, the patient files 
were linked to provide individual level information on 
demographic characteristics, medical and drug histories, as 
well as on their vital status. For characteristics of the rural–
urban general population, the 2001 Canadian census data 
was used. 
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Figure 1:  Rural–urban areas according to the statistical area classification definition. CA, census agglomerations; CMA, 
census metropolitan areas; MIZ, metropolitan influenced zones. 
 
 
Study populations 
 
In this study, atherosclerosis, osteoporosis and diabetes were 
chosen as representative of chronic diseases because these 
diseases have high prevalence, represent important morbid 
conditions, and guidelines have been published to treat them 
and to prevent complications. Exhaustive cohorts in the early 
2000s were selected for each disease using the following 
selection criteria  
 
• patients newly hospitalized for a myocardial 
infarction (MI) 
• patients who had suffered a fragility fracture (FF) 
• incident cases of diabetic (DB) patients.  
 
The study period varied between the cohorts in order to have 
a sufficient follow-up time (one or 2 years depending on the 
disease) and to have a fairly large number of cases. 
 
Myocardial infarction:  The study population included 
patients 25 years and older, living in the province of Quebec, 
hospitalized for a MI (code 410 of the International Disease 
Classification, 9th revision; IDC-9) between January 2000 
and December 2003. The date of the first hospitalization 
during the study period was defined as the index date. In 
order to include only new cases, all patients who had a 
previous hospitalization for MI during the year preceding the 
index date were excluded. Patients for whom place of 
residence data were missing were also excluded. This cohort 
was followed for one year. 
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Fragility fractures:  The studied population consisted of all 
individuals 40 years or older hospitalized for a fracture at a 
site of FF or for whom a physician claimed a medical service 
for an FF between January 2000 and December 2002. The 
following fractures were considered potential osteoporotic 
fractures or FFs: vertebral (ICD-9 code 805), pelvis (ICD-9 
code 808), proximal humerus (ICD-9 code 812), wrist (ICD-
9 code 814) or hip (ICD-9 code 820-821). The date of the 
first consultation for one of the above-mentioned fractures 
was defined as the index date. In order to include new cases 
only, all patients who had a previous consultation for FF 
during the 1 year period preceding the index date were 
excluded. In order to enhance the specificity of the diagnosis 
of FF with the use of medico-administrative database, those 
who had a motor vehicle accident or a work-related accident 
in the week preceding the index date were also excluded 
because those fractures were less likely to be osteoporosis-
related38. Patients for whom data on place of residence were 
missing were also excluded. This cohort was followed for a 
2 year period. 
 
Diabetes:  The study population included all diabetic 
patients 20 years and older, living in the province of Quebec, 
between January 2001 and December 2002. Based on 
Blanchard et al39, a record in administrative data was 
considered to be a diabetes case if the individual was 
hospitalized with a diagnosis of diabetes (code 250 IDC-9) 
with either one of the 16 diabetes-related diagnostic codes 
(MED-ECHO register) or had at least two physician claims 
within 2 years with the diagnostic code of diabetes (ICD-9 
code 250) (physician visits register). This algorithm has been 
validated and is widely used in Canada40 and in particular by 
the National Diabetes Surveillance System (NDSS) of 
Canada. The date of the first consultation for diabetes within 
the study period was defined as the index date. Only newly 
diagnosed patients with diabetes (incident cases) were 
included by excluding patients that received one diagnosis of 
diabetes within 5 years before the index date41. Patients with 
missing place of residence data were removed from the 
cohort. This cohort was also followed for a 2 year period. 
 
 
Study variables 
 
A list of issues for each of the three chronic diseases was 
selected. These issues were classified in seven categories 
(Table 1): incidence, mortality, morbidity, material and 
human resources utilization, and drug treatment. 
 
Incidence:  The incidence of MI was estimated by ratio 
between the total number of patients with a hospitalization 
for MI during the study period (2000-2003) and the total 
population 25 years and older in the province of Quebec in 
2001. The incidence of FF was estimated by ratio between 
the total number of patients with a consultation for a new FF 
during the study period (2000-2002) and the total population 
40 years and older in the province of Quebec in 2001. The 
incidence of diabetes was estimated by ratio between the 
total number of newly diagnosed diabetes cases (according 
to the definition used by the NDSS) during the study period 
(2000-2001) and the total population 20 years and older in 
the province of Quebec in 2001. 
 
Mortality:  The cardiovascular disease (CVD) mortality rate 
at one year for MI patients was calculated by the proportion 
of patients who died from a CVD cause (ICD-9 410-414; 
426-429) within one year after the index date. The all-cause 
mortality rate at one year for patients with FF was calculated 
by the proportion who died within one year after the index 
date. Because the death rate at one year for diabetic patients 
was very small, an all-cause mortality rate at 2 years for 
diabetic patients was calculated. 
 
Morbidity:  For the atherosclerotic population, morbidity 
was measure by the proportion of MI patients that were 
hospitalized for a CVD (ICD-9 410-414; 426-429) within 
one year after the index hospitalization among those 
discharged alive. For the osteoporotic population, morbidity 
was measured by the proportion of patients with an FF at 
another site within one year after the index date. Finally, for 
the diabetic population, morbidity was measured as the 
proportion of newly diagnosed diabetic patients who were 
hospitalized (for any cause) within 2 years of the index date. 
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Table 1:  List of selected issues for each chronic disease 
 
Chronic disease Issue 
Atherosclerosis Osteoporosis Diabetes 
Incidence Incidence MI Incidence FF Incidence DB 
Mortality CVD mortality  
(12 months) 
All-cause mortality (12 months) All-cause mortality (24 months) 
Morbidity  Readmission CVD  
(12 months) 
Other FF  
(12 months) 
Hospitalization  
(12 months) 
Material resources 
utilization 
Index revascularization BMD testing 
(2 years) 
 
− 
Human resources 
utilization 
Generalist, internist, cardiologist 
(3 months) 
Generalist, internist, 
rheumatologist 
(3 months) 
Generalist, internist, 
endocrinologist 
(3 months) 
Drug treatment ASA, BB, ACE, Statins  
(12 months) 
BIS, HRT  
(12 months) 
Insulin, metformin, Secretagogue  
(12 months) 
ACE, ACE-inhibitor; ASA, aspirin; BB, beta-blockers; BIS, bisphosphonate; CVD, cardiovascular disease; HRT, hormonal replacement therapy. 
 
 
Material resources utilization:  Among MI patients who 
survived index hospitalization, the proportion of those who 
received either a percutaneous transluminal coronary 
angioplasty or a coronary artery bypass graft at index 
hospitalization was calculated. For those who suffer from an 
FF, a bone mineral density (BMD) test can be performed as a 
diagnostic test for osteoporosis. If there was a medical 
service with a dual-energy X-ray absorptiometry procedure 
within 2 years after the index date, the patient was 
considered to have undergone a BMD testing. Diabetic 
patients are recommended to undergo dilated eye 
examination; however, it was not possible to recover valid 
information about this procedure because it can be 
performed at the optometrist’s office, which is not covered 
by the provincial data bases.  
 
Human resources utilization:  For each disease, the 
proportion of patients who had seen a generalist within 
3 months after the index date were calculated. The 
proportion who consulted an internist or another specialist 
(cardiologist, rheumatologist or endocrinologist) in the same 
period was also calculated. 
 
Drug treatment:  For this category of variables, only 
patients covered by the public insurance plan were included 
in the calculations, representing more than two-third of the 
present study populations. Post-MI treatments considered 
were the use of aspirin (ASA), beta-blockers (BB), ACE 
inhibitors or statins. Patients were considered to be under a 
specific treatment if there was at least one pharmacy claim of 
the selected drugs one year after the index date. Individuals 
were considered to have received osteoporosis related 
treatment if there was at least one pharmacy claim for a 
bisphosphonate (BIS) or at least one pharmacy claim for an 
ovarian hormonal replacement therapy (HRT; for women) 
within one year after the index date. For diabetic patients, 
insulin, metformin and secretagogue drug use were 
considered one year after the index date. 
 
Analyses 
 
All rates were adjusted for age and sex. For comparing 
adjusted rates among categories of rural–urban areas, the 
relative risks (RR) were calculated on adjusted rates using 
the metropolitan areas (CMA) as the reference group. The χ2 
test was used to test for the difference of risk between a 
specific group and the reference group. Because of large 
sample sizes, the statistical level of significance was set to 
0.01. A summary table (Table 2) was made in order to 
compare results across the three chosen diseases. In this 
table, color-coded arrows indicate statistically significant 
(p <0.01) and clinically significant increase (arrow up) or 
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decrease (arrow down) in issues belonging to the categories 
(incidence, mortality, morbidity, material resources 
utilization, general and specialist consultations and drug 
treatments). Clinically significant increase or decrease means 
at least a 20% difference in the risk compared with the 
reference group (RR or 1/RR ≥1.2). This threshold of 1.2 in 
the relative risk was proposed by Hopkins42 and was based 
on a scale proposed by Cohen43 for different measures of 
effect size. 
 
Ethical considerations 
 
This study was approved by the University Hospital Ethics 
Board and the Commission d’accès à l’information du 
Québec. 
 
Results 
 
Table 3 presents the characteristics for the general 
population of Quebec according to place of living (rural or 
urban). Almost 66% of the Quebec population lives in a 
metropolitan area (CMA) and 12% in a small town (CA). 
The ratio of women to men is higher in urban areas (CMA 
and CA) when compared with the other regions (MIZ). 
Small towns and moderate MIZ have the highest rate of 
elderly people. A clear urban to rural gradient is notable in 
median income, unemployment rate and in the rate of people 
without secondary school diploma. However, the reverse is 
true regarding social conditions such as the rate of people 
living alone. 
 
The atherosclerotic cohort included a total of 44 806 patients 
with a MI between 2000 and 2003. Generally, more than 
one-third of patients with MI were women and the mean age 
was 66.5 years. The sex and age distribution differs between 
rural and urban areas, the proportion of women and the mean 
age being the lowest in strong MIZ (Table 4). The cohort of 
patients with FFs included a total of 64 540 individuals 
between 2000 and 2002. As opposed to atherosclerosis, 
women are generally more prone to suffer from a fragility 
fracture than men. The sex and age distribution seems also to 
differ between rural and urban areas, the proportion of 
women and the mean age being once again nearly the lowest 
in strong MIZ and No MIZ areas (Table 4). A total of 71 857 
patients were newly diagnosed with diabetes between 2001 
and 2002. Men were slightly more frequently diagnosed than 
woman and were younger at diagnosis, particularly in strong 
MIZ (Table 4). 
 
Incidence 
 
No rural–urban common pattern in the incidence rates 
emerges across the three chronic diseases (Tables 2,5). The 
first observation is that the MI incidence was the greatest in 
small towns (CA) and in Weak MIZ compared with 
metropolitan areas (CMA). Fragility fractures seem to be 
slightly more frequent in small towns but less frequent in 
more rural areas compared with metropolitan areas. There is 
no clear trend in the incidence of diabetes among rural–
urban regions. However, a clinically and statistically 
significantly smaller risk of diabetes was observed in 
moderate MIZ (Table 2). 
 
Mortality 
 
No difference between rural and urban areas in the mortality 
rates is observed across all three chronic diseases 
(Tables 2,5). The age and sex adjusted mortality rates did not 
differ significantly between urban and rural areas for all 
selected chronic diseases (Table 5). 
 
Morbidity 
 
No clear, common rural–urban pattern in the morbidity rates 
was observed across the three chronic diseases (Tables 2,5). 
For atherosclerosis and diabetes, the adjusted rates of 
morbidity were significantly higher in non-metropolitan 
areas than in metropolitan areas with the highest rates found 
in remote regions (weak and no MIZ). For osteoporosis, the 
morbidity rate was significantly lower in the strong MIZ area 
only (Table 5).  
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Table 2:  Summary table of statistically and clinically significant adjusted relative risks for the three selected chronic 
diseases: atherosclerosis (n=44 806), osteoporosis (n=64 540), and diabetes (n=71 857) 
 
 CA Strong  
MIZ 
Moderate 
MIZ 
Week  
MIZ 
No  
MIZ 
Incidence ↑= = = = = = = ↓ ↑↓= ↑= = 
Mortality = = = = = = = = = = = = = = = 
Morbidity ↑ = = =↓= = = = ↑ = ↑ ↑ = ↑ 
Material Res. utilization ↓↓ nd =↓ nd =↓ nd ↓↓ nd ↓↓ nd 
Human Res. utilization ↕↓↓ ↕↓↓ ↕↓↓ ↕↓↓ ↕ =↓ 
Drug treatment = ↑ = = ↑ = = = = = = = = = = 
↑↓= Atherosclerosis; ↑↓ = osteoporosis ; ↑↓= diabetes. 
CA, Small town; MIZ, metropolitan influenced zones; nd, no data; Res., resources. 
The table summarizes the results of Tables 4 to 9. It indicates the adjusted relative risk direction when compared to the reference group 
CMA. An arrow up means a greater, statistically (P < 0.01) and clinically significant risk (RR ≥ 1.2) whereas an arrow down means a lower, 
statistically (P < 0.01) and clinically significant risk (1/RR ≥ 1.2 or RR ≤ 0.83) risk as compared with the risk in a census metropolitan areas. 
An arrow in both directions indicates that one representative has a significantly higher RR and one has a significantly lower RR. Similar 
relative risks (statistically or clinically non significant) are represented by the equality symbol =.
 
 
 
Table 3:  Description of the rural–urban population44 
 
Location Variable 
Quebec CMA CA Strong MIZ Mod. MIZ Weak MIZ No MIZ 
Population  
n (%) 
7 237 270 4 812 885 (66.5) 868 495 (12.0) 439 820 (6.1) 790 005 (10.9) 279 405 (3.9) 46 660 (0.6) 
Female sex % 51.2 51.8 51.4 49.0 49.9 50.0 49.0 
≥ 65 years % 13.3 12.8 14.3 12.1 15.4 13.6 11.5 
Median income ($) 
Male 
 
27 519 
 
28 610 
 
27 052 
 
26 116 
 
23 616 
 
24 869 
 
22 081 
Female  16 800 17 966 15 128 14 799 13 636 13 577 14 282 
Unemployment rate† % 7.6 6.7 8.3 7.8 9.5 13.7 16.7 
Without secondary 
school diploma§ % 
29.9 25.7 33.8 36.5 42.3 43.2 50.0 
People living alone % 12.4 13.1 13.0 9.0 10.8 9.8 8.6 
CA, census agglomerations; CMA, census metropolitan areas; MIZ, metropolitan influenced zones; mod., moderate. 
† ≥25 years; § ≥20 years.
 
  
 
 
Material resources utilization 
 
A common pattern emerged across the three chronic diseases 
(Tables 2,6) regarding material resources utilization. Index 
revascularization rates were lower in all non-metropolitan 
areas regions as opposed to metropolitan areas (Table 2) but 
surprisingly the index revascularization rate was lower in 
small towns compared with some rural areas (strong and 
moderate MIZ). The most striking observation was the 
underutilization of an osteodensitometry (18.8% overall) 
with very low rates in non-metropolitan areas, resulting in 
possible under diagnosis of osteoporosis (Table 6). 
Human resources utilization 
 
A common pattern emerges across the three chronic diseases 
(Tables 2,6) regarding specialist human resources utilization. 
There was no clear trend in the generalist consultation rate 
across rural and urban areas (Table 6). However, specialists 
other than internist were dramatically less consulted in non-
metropolitan areas as opposed to metropolitan areas. 
However, MI patients living outside metropolitan areas were 
more likely to be consulting internists (this trend was not 
observed for the other two chronic diseases). 
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Table 4:  Description of each cohort of chronic disease patients according to their rural or urban place of living 
 
Location Chronic disease 
Quebec CMA CA Strong MIZ Mod. MIZ Weak MIZ No MIZ 
Atherosclerosis 
Total  n (%) 44 806 (100) 26 856 (59.9) 6 639 (14.8) 2 904 (6.5) 6 028 (13.5) 2 090 (4.7) 289 (0.6) 
Female sex (%) 34.9 35.7* 35.9 28.8** 33.5 34.1 33.6 
Mean age (years) 66.5 66.5 66.9 65.3** 67.3* 66.4 66.2 
Osteoporosis 
Total n (%) 64 540 (100) 42 083 (65.2) 9 020 (14.0) 3 621 (5.6) 7 473 (11.6) 2 043 (3.2) 300 (0.5) 
Female sex (%) 68.5 70.8* 66.8** 61.4** 64.4** 63.3** 60.3** 
Mean age (years) 70.2 70.5* 69.4** 67.4** 70.5 71.0 67.4** 
Diabetes 
Total  n (%) 71 857 (100) 47 412 (66.0) 8 755 (12.2) 4 559 (6.3) 7 901 (11.0) 2 745 (3.8) 485 (0.7) 
Female sex (%) 45.6 45.8 45.5 42.0** 45.5 47.5 47.6 
Mean age (years) 60.5 60.2** 61.0* 59.9** 62.2* 61.2 59.4 
CA, census agglomerations; CMA, census metropolitan areas; MIZ, metropolitan influenced zones; mod., moderate. 
*Significantly higher (p < .01) than Quebec; **significantly lower (p < .01) than Quebec 
 
 
Table 5:  Age and sex adjusted relative (to CMA) risks of incidence, mortality and morbidity of chronic diseases according 
to rural or urban place of living 
 
Location Chronic disease 
CMA (ref) CA Strong MIZ Mod. MIZ Weak MIZ No MIZ 
Atherosclerosis 
Incidence MI 0.84% 1.24*** 1.15*** 1.16*** 1.24*** 1.21* 
CVD mortality  12.3% 1.02 0.91 0.92* 0.89 0.78 
Readmission CVD 23.3% 1.21*** 1.15*** 1.16*** 1.32*** 1.39** 
Osteoporosis 
Incidence FF 1.87% 1.08*** 1.03 0.95*** 0.80*** 0.86* 
All-cause mortality 12.9% 0.98 1.02 0.99 0.90 0.94 
Other FF 10.3% 0.92 0.82** 0.92 0.95 1.08 
Diabetes 
Incidence DB 1.34% 0.95*** 1.02 0.90*** 0.95 1.15* 
All-cause mortality 6.0% 0.95 1.09 0.94 1.00 0.93 
Hospital admission 23.7% 1.10*** 1.14*** 1.10*** 1.29*** 1.30** 
CA, census agglomerations; CMA, census metropolitan areas; CVD, cardiovascular disease; DB, diabetes; FF, fragility 
fracture; MI, myocardial infarction; MIZ, metropolitan influenced zones; mod., moderate. 
*P < 0.01; **P < 0.001; ***P < 0.0001
 
 
 
Treatment 
 
No difference between rural and urban areas in most drug 
utilization rates was observed across all three chronic 
diseases (Tables 2,7). Cardio-protective drug treatment rates 
and diabetes-related drugs were very similar between rural 
and urban regions, likewise for osteoporosis-related drug 
bisphosphonates. Hormone replacement therapy, however, 
was more privileged outside metropolitan areas (Table 7). 
In summary, many similarities in results exist across the 
three chronic diseases when they are compared with 
metropolitan areas (CMA). The material resources utilization 
rates and the non-internist specialist consultation rates were 
lower, while the morbidity rates were higher or similar 
outside metropolitan areas compared with metropolitan areas 
(CMA). However, mortality rates and drug utilization rates 
were very similar among regions, except for HRT rates. 
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Table 6:  Age and sex adjusted rates relative (to CMA) risks of human and material resources utilization according to 
chronic disease and rural–urban place of living 
 
Location Chronic disease 
CMA (ref) CA Strong MIZ Mod. MIZ Weak MIZ No MIZ 
Atherosclerosis 
Index revascularization 44.7% 0.82*** 0.86*** 0.85*** 0.74*** 0.65*** 
Generalist 74.5% 1.15*** 1.10*** 1.10*** 0.93*** 0.97 
Internist 12.9% 2.47*** 1.60*** 1.54*** 2.08*** 2.55*** 
Cardiologist 65.3% 0.56*** 0.74*** 0.67*** 0.44*** 0.40*** 
Osteoporosis 
BMD 21.1% 0.67*** 0.82*** 0.68*** 0.48*** 0.56** 
Generalist 64.1% 1.01 0.99 1.03* 0.95* 0.92 
Internist 8.4% 0.89* 0.66*** 0.61*** 0.69*** 0.70 
Rheumatologist 2.3% 0.34*** 0.48*** 0.47*** 0.38*** NA 
Diabetes 
Generalist 68.4% 1.06*** 1.01 1.04*** 0.88*** 0.82*** 
Internist 9.0% 1.04 0.97 0.80*** 1.13 1.17 
Endocrinologist 9.0% 0.24*** 0.37*** 0.35*** 0.25*** 0.25*** 
CA, census agglomerations; BMD, bone mineral density; CMA, census metropolitan areas; MIZ, metropolitan influenced 
zones; mod., moderate; NA, unavailable due to very small numbers. 
*P < 0.01; **P < 0.001; ***P < 0.0001 
 
 
Table 7:  Age and sex adjusted relative (to CMA) risks of disease-related drug treatment according to chronic disease and 
rural or urban place of living 
 
Location Chronic disease 
CMA (ref) CA Strong MIZ Mod. MIZ Weak MIZ No MIZ 
Atherosclerosis 
Aspirin 86.3% 1.01 1.03** 1.03** 0.98 0.97 
Beta-blockers 81.2% 0.98 1.02 1.00 0.95* 0.97 
ACE inhibitors 74.7% 1.00 1.02 1.05*** 1.03 1.04 
Statins 72.1% 0.99 1.02 1.03 1.02 1.03 
Osteoporosis 
Bisphosphonates 23.4% 1.04 1.05 1.00 1.02 0.91 
HRT 10.8% 1.29*** 1.22* 1.14* 1.22 1.18 
Diabetes 
Insulin  3.3% 0.81 0.88 0.97 0.99 0.97 
Metformin  40.2% 1.01 1.04 1.04 1.03 0.99 
Secretagogue  23.8% 0.93* 0.95 0.92* 0.98 0.87 
CA, census agglomerations; CMA, census metropolitan areas; HRT, hormonal replacement therapy; MIZ, metropolitan 
influenced zones; mod., moderate. 
*P < 0.01; **P < 0.001; ***P < 0.0001 
 
 
Discussion 
 
The main objective of this study was to describe systematic 
gaps across rural and urban populations in incidence, 
mortality, morbidity, material and human resources 
utilization, and drug management for three specific chronic 
diseases, namely atherosclerosis, osteoporosis and diabetes. 
A common pattern emerged: for all three diseases, the 
material resources utilization rates and the specialist (except 
internist) consultation rates were almost always lower and 
the morbidity rates higher in small towns and rural areas 
when compared with metropolitan areas. However, mortality 
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rates and drug utilization rates were very similar among 
regions, except for HRT in women, where utilization rates 
were higher in small towns and rural areas compared with 
metropolitan areas. 
 
The MI incidence was greater in small towns and in Weak 
MIZ compared with metropolitan areas. This is consistent 
with other studies45,46, but not with some results of Martinez 
et al24 who found that mortality rate from ischemic 
cardiopathy in urban areas (including small towns) was 
higher than in rural areas. However, they also showed a 
higher prevalence self-reported heart disease in rural areas.  
 
Although hospital readmission rate for CVD was 
significantly higher in all non-metropolitan areas and index 
revascularization and specialist consultation rates 
significantly lower in all these regions, the mortality rate 
12 months after MI did not differ significantly between rural 
and urban areas. It is not surprising that the index 
revascularization rate was higher in metropolitan areas 
considering that this procedure is available only in 
specialized cardiology centers which are all located in 
metropolitan areas. Previous results show that although 
invasive procedures reduce morbidity (non-fatal outcomes) 
and enhance quality of life47-49, their availability at the 
admitting hospital has no effect on post-infarction 
survival50,51. The results of the present study are consistent 
with these findings because the survival rate of individuals 
living in metropolitan areas is not better than those living in 
non-metropolitan areas. 
 
Fragility fractures seem to be slightly more frequent in small 
towns but less frequent in rural areas when compared with 
metropolitan areas. A lower incidence of FFs in rural areas 
has been reported in other studies52,53. A striking observation 
is the underutilization of an osteodensitometry (18.8% in 
Quebec), with even lower rates outside metropolitan areas, 
resulting potential under-diagnosis of osteoporosis. Once 
again, internist and other specialist consultation rates were 
lower in rural areas, but generalist consultation rates and 
bisphosphonates drug utilization remained essentially the 
same among regions. These results are partly consistent with 
another study on osteoporotic fractures conducted in Ontario 
which revealed that women, but not men, in an urban area 
were more likely to be taking a bone-sparing agent compared 
with those living in a rural area54. They also revealed that 
estrogen was more privileged in non-metropolitan areas, 
which is consistent with the present study results.  
 
There was no clear trend in the incidence of diabetes among 
rural and urban regions. However, an increased risk was 
observed in remote regions and a smaller risk in moderate 
MIZ compared with metropolitan areas. It is well known that 
Aboriginal people are at greater risk of diabetes compared 
with the general population of Canada55, explaining the 
increased risk observed in remote Quebec (No MIZ). 
Endocrinologists were dramatically less consulted but there 
were more hospitalizations outside metropolitan areas. Once 
again, mortality and diabetes-related drug use were 
comparable among regions. Similarly to the present study, 
no rural–urban difference in adjusted mortality rates was 
observed in a study conducted in another province of Canada 
(Saskatchewan)56.  
 
This study found systematically less material resource 
utilization and less specialist consultations but generally 
more morbidities in some rural areas compared with 
metropolitan areas. These findings together with other 
studies23,24 reporting higher proportions of smokers, lower 
consumption of fruit and vegetables and higher proportion of 
individuals who are overweight among rural residents, 
suggest that there may be potential in rural-friendly 
approaches in disease prevention and health promotion. 
 
Another important observation is that small towns (CA), 
often included as urban areas, differ from the other regions 
regarding health issues and healthcare management. In fact, 
small towns and moderate MIZ are more alike in terms of 
material and human resources utilization and also in terms of 
morbidity, while strong MIZ, which are peripheral to urban-
suburban areas, seem to have better access to material and 
human resources than patients living in small towns. This 
motivates the separation of small towns (CA) from 
metropolitan areas (CMA) from the definition of ‘urban 
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areas’. The particularity of strong MIZ has been also noted 
in another study57. The population living in these regions are 
distinct from the others as they show a greater proportion of 
risk factors such as tobacco use, physical inactivity and 
obesity, with increased negative perceptions regarding their 
social life and their health status. 
 
The major strength of this study is its naturalistic approach 
as it includes the entire province of Quebec, which is 
interesting from a public health perspective since it provides 
province-based knowledge, incorporating geographical 
variables in the studies of an important health problem. In 
the long term this may contribute to improving prevention 
and intervention programs. The importance of disease 
prevention and health promotion is well recognized in public 
health and clinical settings.  
 
The present study has some limitations because it was based 
on medico-administrative databases that are not usually 
validated for epidemiological research. However, the validity 
of the administrative hospital discharge data regarding other 
chronic diseases such as MI has previously been 
published58,59. The accuracy of the prescription claims 
database in Quebec was also confirmed by previous 
studies60. However, because the prescription claims database 
covers people 65 years and older, those on welfare and all 
people not covered by a private insurance plan, some results 
may not be generalizable to all populations. A potential 
information bias can arise in diagnosis reporting because 
medical visits at the local community health center are not 
always registered in the databases.  
 
Conclusions 
 
It was found that for all three chronic diseases – myocardial 
infarction, osteoporosis, and diabetes – there was 
substantially lower utilization of specialized services in non-
metropolitan areas. However, this did not translate into 
consistent differences in mortality and morbidity outcomes. 
This suggests that the impact of differential care utilization is 
specific to each disease, with indications that some important 
services may be under-utilized in rural areas, but others may 
be over-utilized in urban areas without improvement in 
outcomes. Accordingly, how differences in utilization of 
specialized medical care affect outcomes in relation to rural 
or urban residence in Quebec need to be examine in more 
details using disease specific studies.  
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